Rehashing Endocannabinoid Antagonists: Can We Selectively Target the Periphery to Safely Treat Obesity and Type 2 Diabetes?

Journal of Clinical Investigation - United States
doi 10.1172/jci44099
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy